Infosys Limited Income Statement Quarterly
INFY
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
INCOME STATEMENT (Quarterly GAAP In millions $) |
(Mar 31 2023) IV. Quarter |
0 III. Quarter |
0 II. Quarter |
0 I. Quarter |
(Mar 31 2022) IV. Quarter |
Revenue From Contracts With Customers |
|
- |
- |
- |
|
Revenue |
|
- |
- |
- |
|
Cost Of Sales |
|
- |
- |
- |
|
Total Revenue |
18,212.00 |
0.00 |
0.00 |
0.00 |
16,311.00 |
Cost Of Sales |
12,709.00 |
- |
- |
- |
10,996.00 |
Gross
Profit |
5,503.00 |
0.00 |
0.00 |
0.00 |
5,315.00 |
Selling, Administration, Marketing |
- |
- |
- |
- |
- |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research & development |
- |
- |
- |
- |
- |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
1,678.00 |
- |
- |
- |
-1,560.00 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Total operating costs including COS |
14,387.00 |
- |
- |
- |
12,556.00 |
Operating income/-loss
|
3,825.00 |
- |
- |
- |
3,755.00 |
Other Deductions / - Income |
Interest expense |
- |
- |
- |
- |
- |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
- |
- |
- |
- |
- |
Loss/ -Gain on Investment |
- |
- |
- |
- |
- |
Foreign Currency Transaction (Gain) Loss |
- |
- |
- |
- |
- |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-300.00 |
- |
- |
- |
-281.00 |
Total costs & expenses |
14,087.00 |
0.00 |
0.00 |
0.00 |
12,275.00 |
Income /-loss before income taxes |
4,125.00 |
0.00 |
0.00 |
0.00 |
4,036.00 |
Income taxes expenses/-benefit |
1,142.00 |
- |
- |
- |
1,068.00 |
Income after income taxes |
2,983.00 |
0.00 |
0.00 |
0.00 |
2,968.00 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
2,983.00 |
0.00 |
0.00 |
0.00 |
2,968.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
2,983.00 |
0.00 |
0.00 |
0.00 |
2,968.00 |
Noncontrolling interests |
2.00 |
- |
- |
- |
5.00 |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
2,981.00 |
0.00 |
0.00 |
0.00 |
2,963.00 |
EBIT |
4,125.00 |
0.00 |
0.00 |
0.00 |
4,036.00 |
EBITD |
4,125.00 |
0.00 |
0.00 |
0.00 |
4,036.00 |
EBITDA |
4,125.00 |
0.00 |
0.00 |
0.00 |
4,036.00 |
Per
Share (GAAP Quarterly, in $) |
(Mar 31 2023) IV. Quarter |
0 III. Quarter |
0 II. Quarter |
0 I. Quarter |
(Mar 31 2022) IV. Quarter |
Basic EPS (excl. extra
items) |
0.71 |
0.00 |
0.00 |
0.00 |
0.70 |
Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Basic Net EPS |
0.71 |
0.00 |
0.00 |
0.00 |
0.70 |
Basic shares outstanding (Mill.
of Units) |
4,180.90 |
0.00 |
0.00 |
0.00 |
4,209.55 |
EPS other shares |
- |
- |
- |
- |
- |
Diluted Net EPS |
0.71 |
0.00 |
0.00 |
0.00 |
0.70 |
Diluted average shares (Mill.
of Units) |
4,187.73 |
4,187.73 |
4,187.73 |
4,187.73 |
4,218.53 |
Dividend per share |
0.405 |
- |
- |
- |
0.404 |
|
|